It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In mammals, hypoxic stress management is under the control of the Hypoxia Inducible Factors, whose activity depends on the stabilization of their labile α subunit. In particular, the skeletal muscle appears to be able to react to changes in substrates and O2 delivery by tuning its metabolism. The present study provides a comprehensive overview of skeletal muscle metabolic adaptation to hypoxia in mice and in human subjects exposed for 7/9 and 19 days to high altitude levels. The investigation was carried out combining proteomics, qRT-PCR mRNA transcripts analysis, and enzyme activities assessment in rodents, and protein detection by antigen antibody reactions in humans and rodents. Results indicate that the skeletal muscle react to a decreased O2 delivery by rewiring the TCA cycle. The first TCA rewiring occurs in mice in 2-day hypoxia and is mediated by cytosolic malate whereas in 10-day hypoxia the rewiring is mediated by Idh1 and Fasn, supported by glutamine and HIF-2α increments. The combination of these specific anaplerotic steps can support energy demand despite HIFs degradation. These results were confirmed in human subjects, demonstrating that the TCA double rewiring represents an essential factor for the maintenance of muscle homeostasis during adaptation to hypoxia.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Department of Biomedical Sciences for Health, University of Milan, Segrate, (MI), Italy
2 UO Proteomica Clinica, IRCCS Policlinico San Donato, San Donato Milanese, (MI), Italy
3 CNR-Institute of Bioimaging and Molecular Physiology, Cefalù, (PA) and Segrate, (MI), Italy
4 Department of Health Sciences, University of Milan, Milan, Italy
5 Centre for Altitude, Space, and Extreme Environment Medicine, University College London (UCL), Institute of Child Health, University College London, London, UK; Anaesthesia and Critical Care Research Unit, University Hospital Southampton, NHS Foundation Trust, Southampton, UK; Integrative Physiology and Critical Illness Group, Division of Clinical and Experimental Science, Faculty of Medicine, University of Southampton, Southampton, UK
6 Department of Biomedical Sciences for Health, University of Milan, Segrate, (MI), Italy; UO Proteomica Clinica, IRCCS Policlinico San Donato, San Donato Milanese, (MI), Italy; CNR-Institute of Bioimaging and Molecular Physiology, Cefalù, (PA) and Segrate, (MI), Italy